These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to 'tardive' dyskinesia independent of extent of neuroleptic medication. Waddington JL; Youssef HA Ir Med J; 1985 May; 78(5):143-6. PubMed ID: 2861172 [No Abstract] [Full Text] [Related]
8. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables. Ezrin-Waters C; Seeman MV; Seeman P J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715 [TBL] [Abstract][Full Text] [Related]
9. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810 [TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia in chronic schizophrenic inpatients. Kua EH; Ang PC; Siew HC Singapore Med J; 1982 Feb; 23(1):19-21. PubMed ID: 6126008 [No Abstract] [Full Text] [Related]
11. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents]. Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377 [TBL] [Abstract][Full Text] [Related]
15. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients. Silver H; Geraisy N; Schwartz M J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856 [TBL] [Abstract][Full Text] [Related]